These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1323775)

  • 21. HCV seroprevalence in dialysis patients, their relatives and medical staff.
    Capşa D; Cernescu S; Constantinescu SN; Cernescu C
    Rev Roum Virol; 1991; 42(3-4):171-5. PubMed ID: 1667584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis.
    Vandelli L; Medici G; Savazzi AM; De Palma M; Vecchi C; Zanchetta G; Lusvarghi E
    Nephron; 1992; 61(3):260-2. PubMed ID: 1323767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies.
    Vasile A; Allegra V; Canciani D; Forchì G; Mengozzi G
    Nephron; 1992; 61(3):318-9. PubMed ID: 1323779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV infections in dialysis patients.
    Scotto G; Savastano AM; Forcella M; Tantimonaco G; Amato G; Salatino G; Pappani A; Stella I
    Nephron; 1992; 61(3):320-1. PubMed ID: 1323780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
    Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
    J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group.
    Nephrol Dial Transplant; 1995; 10 Suppl 6():78-80. PubMed ID: 8524503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.
    Lin HH; Huang CC; Sheen IS; Lin DY; Liaw YF
    Am J Nephrol; 1991; 11(3):192-4. PubMed ID: 1660221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies.
    La Russa A; Bufano G; Cauzzi L; Pecchini P
    Nephron; 1992; 61(3):273-5. PubMed ID: 1323770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them.
    Blackmore TK; Stace NH; Maddocks P; Hatfield P
    Aust N Z J Med; 1992 Aug; 22(4):353-7. PubMed ID: 1280095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
    Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
    Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis C antibodies in health-care workers. Italian Study Group on Blood-borne Occupational Risk in Dialysis.
    Petrosillo N; Puro V; Ippolito G
    Lancet; 1994 Jul; 344(8918):339-40. PubMed ID: 7519711
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C virus infection among kidney transplant recipients.
    Ponz E; Campistol JM; Bruguera M; Barrera JM; Gil C; Pinto JB; Andreu J
    Kidney Int; 1991 Oct; 40(4):748-51. PubMed ID: 1720826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients.
    Da Porto A; Poli P; Calzavara P; Castelletto MR; Adami A; Cascone C; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):367-8. PubMed ID: 1323794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.